CRISPR Therapeutics AG Equity-NMS: CRSP

Healthcare

Biotechnology

Buy/Sell an entire stock
or a fraction.

Vested

Already an existing customer?

New User?

Open Your Free Demat Account And Start Trading Seamlessly

Loading, Please wait...

Error in Fetching Data, Please retry later.

No data available.

Previous close :

$77.46

52W high :

$135.7

1Y :

-40.97%

5Y :

300.7%

EPS(TTM): :

-7.9

Shares O/S :

78.01 M

Market cap :

6.14 B

What is the share price of CRISPR Therapeutics AG today?

CRISPR Therapeutics AG (CRSP) share price as of August 12, 2022, is $78.66. If you are investing from India, you can always check the valuation in the INR before investing.

Can Indian Investors purchase shares of CRISPR Therapeutics AG?

Yes, Indian Investors can invest in the CRISPR Therapeutics AG (CRSP) Share by opening an international trading account with Angel One.

How can I purchase CRISPR Therapeutics AG shares in India?

Purchasing CRISPR Therapeutics AG (CRSP) share from India can be done by:

Directly: By opening an international trading account with Angel One. The process would include KYC verification.
The account activation takes a few minutes to a few hours, after which you can start buying CRISPR Therapeutics AG (CRSP) by making deposits in US dollars.
Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.

Can I buy Fractional shares of CRISPR Therapeutics AG?

Yes, you can purchase fractional shares of CRISPR Therapeutics AG (CRSP) or any other US company shares in Angel One for any dollar amount.

What is the market capitalization value of CRISPR Therapeutics AG?

The market capitalization of CRISPR Therapeutics AG on August 13, 2022, is $6.14 B.

In which sector CRISPR Therapeutics AG belongs?

CRISPR Therapeutics AG operates in the Healthcare sector, specifically in the Biotechnology industry.

What documents are required to invest in CRISPR Therapeutics AG stocks?

In order to invest in CRISPR Therapeutics AG (CRSP) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.)

From start to end, the process is digital and can be seamless.

CRISPR Therapeutics AG is a Switzerland-based gene-editing company. It focuses on the development of transformative gene-based medicines for serious diseases. The Company develops its products using Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas9 gene-editing platform, which allows for precise directed changes to genomic deoxyribonucleic acid (DNA). The Company has a portfolio of therapeutic programs in a range of disease areas, including hemoglobinopathies, oncology, regenerative medicine and rare diseases. Its lead product candidate is CTX001, an ex vivo CRISPR gene-edited therapy for treating patients suffering from transfusion-dependent beta thalassemia or severe sickle cell disease in which a patient’s hematopoietic stem cells are engineered to produce high levels of fetal hemoglobin in red blood cells. The Company has business operations in London and the United Kingdom, as well as research and development operations in the United States.